Morning Quant Ride Feb 2, 2018

Feb 02, 2018

Traders’ Corner

Global markets were generally weak overnight following a flat day yesterday in the US.  Asian was lower with the main headline being the BoJ offering to buy unlimited amounts of bonds for the first time since July.  European markets opened lower and have accelerated losses as the morning session progressed.  A number of notably weak earnings reports helped fuel the profit taking.   A significant selloff in bonds has also induced investors to take profits in stocks.

US markets are fully focused on the US jobs report this morning as well another day of heavy earnings reports.

US equity markets were mixed yesterday: the S&P500 closed down 6 bps while the Russell 2000 closed up 31 bps.  The VIX index, a measure of investor proclivity to hedge, finished down only 7 bps and trading in a range between 14.30 and 12.50.  Mixed results from major large-cap tech companies Apple and Google weighed on US stocks in general: the Nasdaq 100 closed down 70 bps in comparison with the 6 bps move in the S&P500 highlight below.

Yesterday, we released our February Global Top Picks and would encourage investors to focus on our A stocks in underperforming sectors like US staples and US Energy.  Check out our Top Picks US Large-Cap, Top Picks US SMID-Cap, Top Picks US Micro-Cap and Top Picks US Staples models to learn more.

Our Top Picks in the News

Click headline for story

Alphabet (GOOGL)

Alphabet Earnings: Expect Another Beat—Just Barely (Barron’s)

Top Conviction Buy in February, please see Quantamize Global Top Picks US Info Tech report

See more on our Alphabet QuantShot company report from January 11th

Facebook (FB)

Facebook First Look: Let's All Calm Down (Seeking Alpha)

Top Conviction Buy in February, please see Quantamize Global Top Picks US Info Tech report

See more on our Facebook QuantShot company report from January 10th

Alibaba (BABA)

Alibaba Earnings: After Doubling, Could Stock Still Be Cheap? (Barron’s)

Top Conviction Buy in February, please see Quantamize Global Top Picks China report

See more on our Alibaba QuantShot company report from December 5th

Estee Lauder (EL)

Estee Lauder reports Q2 adjusted EPS $1.52, consensus $1.44 (The Fly)  
Top Conviction Buy in February, please see Quantamize Global Top Picks US Large Cap report

Cigna (CI)

Cigna recent selloff a buying opportunity says Leerink (The Fly)
Top Conviction Buy in February, please see Quantamize Global Top Picks US Large Cap report

Kohl's (KSS)

Why Kohl's is back from the brink (Investopedia)
Top Conviction Buy in February, please see Quantamize Global Top Picks US Consumer Discretionary report

Roper Technologies (ROP)

How financially strong is Roper Technologies Inc? (Yahoo Finance)Top Conviction Buy in February, please see Quantamize Global Top Picks US Tech report

See more on our Roper Technologies QuantShot company report from January 9th

Global Indices

Index

Price

1 Day Return

5 Day Return

MTD

YTD

S&P 500

$ 2,821.98

0.00%

-0.54%

0.00%

5.62%

Russell 2000

$ 1,579.87

0.00%

-1.67%

0.00%

2.57%

DJ Industrial Average

$ 26,186.71

0.00%

-0.92%

0.00%

5.79%

NASDAQ Composite Index

$ 7,385.86

0.00%

0.00%

0.00%

7.36%

CBOE Market Volatility Index

14.54

-

-

-

-

Germany DAX (TR)

€ 12,823.35

-1.39%

-0.82%

-0.12%

2.10%

France CAC 40

€ 5,389.43

-1.19%

0.01%

0.20%

3.19%

Japan Nikkei 225

¥ 23,274.53

-0.90%

-2.41%

1.68%

1.46%

Hang Seng Index

¥ 32,601.78

-0.12%

0.71%

-0.75%

9.92%

Hang Seng China Enterprises

¥ 13,538.66

0.78%

1.30%

-0.94%

15.82%

S&P ASX 200

AUD 6,121.40

0.51%

-0.20%

0.87%

-0.45%

Source: FactSet          

Line for QuantShots

Quantalytics Research is the trade name of Quantalytics Research, LLC.

Disclaimer

Quantalytics Research, LLC is not an investment adviser, brokerage firm, or investment company. Any data, information, or opinions presented by Quantalytics Research are for general information purposes only. Such data, information, or opinions are not an offer to sell or to buy, or a solicitation to buy or sell any securities. All investments and investment recommendations entail risks. Any forward looking estimates presented by Quantalytics Research through Quantalytics Edge may prove to be incorrect and not be realized. Any data, information, or opinions expressed in Quantalytics Research in any form may change without notice. Any data, information, or opinions in Quantalytics Research in any form attributed to a third party represent Quantalytics Research's interpretation of the data, information, or opinions provided by that third party either publicly or through a subscription service, and such use and interpretation have not been reviewed by the third party. The data, information and opinions presented have been obtained or derived from sources believed by Quantalytics Research in any form to be reliable. Quantalytics Research, doesn't make any representations as to their accuracy or completeness. Nothing discussed or presented in Quantalytics Research constitutes a representation that any investment, investment strategy, or recommendation is suitable or appropriate to an investor's individual circumstances or otherwise constitutes a personal recommendation. Data, information, or opinions contained in Quantalytics Research in any form give no consideration to any particular individuals' investment needs or objectives, nor do they consider any individuals' financial condition. Consequently, any such data, information, or opinions do not in any way represent a personal recommendation to any individual investor or any entities, whatever the type. Quantalytics Research does not accept any liability for any losses or damages arising from the use of the data, information, or opinions included in Quantalytics Research in any form. All investments involve risks of loss and potential permanent impairment of capital. Investors should diversify risks and exercise prudence and their own judgement in making their investment decisions. Quantalytics Research and any information contained therein is not intended for distribution to or use by any person, or entity, who is a citizen or resident of or located in any locality, state, country, or jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or cause Quantalytics Research, LLC to be required to register or be licensed within any such venues. All data, information, and opinions expressed in Quantalytics Research in any form are as of the date of publication and are subject to change. Quantalytics Research partners and employees may own or have positions in any investment(s) mentioned respectively therein or related thereto and may, from time to time add to, or dispose of, any such investment(s).